Diabetic Nephropathy - Pipeline Insight, 2018

SKU ID : DEL-11679691

Publishing Date : 01-Jan-2018

No. of pages : 90

PRICE
2000
6000


  • Detailed TOC of Diabetic Nephropathy - Pipeline Insight, 2018

    1. Report Introduction
    2. Diabetic Nephropathy Overview
    3. Pipeline Therapeutics
    • An Overview of Pipeline Products for Diabetic Nephropathy
    4. Comparative Analysis
    5. Products in Clinical Stage
    5.1 Drug Name : Company Name
    • Product Description
    • Research and Development
    • Product Development Activities
    6. Products in Pre-Clinical and Discovery Stage
    6.1 Drug Name : Company Name
    • Product Description
    • Research and Development
    • Product Development Activities
    7. Therapeutic Assessment
    • Assessment by Route of Administration
    • Assessment by Stage and Route of Administration
    • Assessment by Molecule Type
    • Assessment by Stage and Molecule Type
    8. Inactive Products
    8.1 Drug Name : Company Name
    • Product Description
    • Research and Development
    • Product Development Activities
    Appendix
    Report Methodology
    Consulting Services
    Disclaimer
    About DelveInsight

    List of Figures, Tables and Charts Available in Diabetic Nephropathy - Pipeline Insight, 2018

    Table 1: Total Products for Diabetic Nephropathy
    Table 2: Products in Clinical Stage
    Table 3: Products in Non-clinical Stage
    Table 4: Assessment by Route of Administration
    Table 5: Assessment by Stage and Route of Administration
    Table 6: Assessment by Molecule Type
    Table 7: Assessment by Stage and Molecule Type
    Table 8: Inactive Products


    Figure 1: Total Products for Diabetic Nephropathy
    Figure 2: Products in Clinical Stage
    Figure 3: Products in Non-clinical Stage
    Figure 4: Assessment by Route of Administration
    Figure 5: Assessment by Stage and Route of Administration
    Figure 6: Assessment by Molecule Type
    Figure 7: Assessment by Stage and Molecule Type
    Figure 8: Inactive Products

    Keyplayers in Diabetic Nephropathy - Pipeline Insight, 2018

    AbbVie Inc
    Allergan Plc
    Antisense Therapeutics Ltd
    Aptevo Therapeutics Inc
    Araim Pharmaceuticals Inc
    Arena Pharmaceuticals Inc
    AstraZeneca Plc
    Bayer AG
    BLR Bio LLC
    Boehringer Ingelheim GmbH
    Cellmid Ltd
    ChemoCentryx Inc
    CSL Ltd
    Daiichi Sankyo Company Ltd
    & list continues...